
Avalon Ventures
Description
Avalon Ventures is a long-established venture capital firm based in La Jolla, California, with a rich history dating back to its founding in 1983. The firm specializes in early-stage investments, primarily targeting the burgeoning sectors of life sciences and information technology. Known for its hands-on approach, Avalon Ventures often engages with entrepreneurs from the very inception of a company, playing a pivotal role in company formation and strategic development. This deep involvement underscores their commitment to nurturing nascent ventures into successful enterprises.
Over its more than three-decade tenure, Avalon Ventures has demonstrated a consistent ability to identify and back promising innovations. The firm has successfully raised 12 venture funds, collectively totaling over $1 billion, which has enabled them to support a diverse portfolio of groundbreaking companies. Their investment strategy typically focuses on seed and Series A rounds, providing crucial early capital to help startups scale. They have invested in over 160 companies, showcasing a broad reach across their target industries.
Avalon Ventures typically deploys initial checks ranging from $1 million to $5 million, with a willingness to provide follow-on funding as their portfolio companies mature and require additional capital for growth. This strategic deployment of capital, combined with their operational expertise, has led to a significant number of successful exits, with over 60 companies achieving liquidity events. Their enduring presence in the venture capital landscape, coupled with a track record of fostering innovation, solidifies Avalon Ventures' reputation as a key player in early-stage technology and life science investments.
Investor Profile
Avalon Ventures has backed more than 185 startups, with 0 new investments in the last 12 months alone. The firm has led 57 rounds, about 31% of its total and boasts 53 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Denmark.
- Strong thematic focus on Software, Health Care, Biotechnology.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (37%)
- Series B (24%)
- Series Unknown (13%)
- Seed (10%)
- Series C (9%)
- Series D (4%)
- Series E (1%)
- Undisclosed (1%)
- Convertible Note (1%)
- Angel (1%)
Country Focus
- United States (97%)
- United Kingdom (2%)
- Denmark (1%)
Industry Focus
- Software
- Health Care
- Biotechnology
- Enterprise Software
- Advertising
- Mobile
- Therapeutics
- Saas
- Medical
- Internet
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.